received approval FDA approves Praluent (alirocumab) announcement Press Release разрешили применение алирокумаба approval разрешили применение алирокумаба approval FDA.gov recently approved the first agent in a brand new class speed the approval of Praluent received approval approved the first new class of cholesterol-lowering drugs